Literature DB >> 15634271

Quantitative high D-dimer value is predictive of pulmonary embolism occurrence independently of clinical score in a well-defined low risk factor population.

J L Bosson1, C Barro, B Satger, P H Carpentier, B Polack, G Pernod.   

Abstract

We performed a prospective study to assess whether positive quantitative D-dimer (DD) levels could be integrated for a selected population in a defined strategy to accurately diagnose pulmonary embolism (PE). For this purpose, 1528 in- or outpatients with clinically suspected PE were investigated according to our prescription rules. Clinical probability was defined as low, intermediate or high. Patients in whom DD levels were measured met criteria defined by our previously described decision-making algorithm: in- and outpatients, < 80 years, without surgery in the previous 30 days or active cancer. Nine hundred and twenty-three patients (60.4%) had quantitative DD measurement using automated latex DD assay (STA-Liatest D-Di). According to our decision-making algorithm, DD measurement was applied to 70.5% of out-, and 55.7% of inpatients, and PE diagnosis was ruled out in 49.5% of the 923 patients. This allowed us to confirm prospectively that our specific rules greatly improve the DD testing efficiency. PE was diagnosed in 115 (12.5%) patients. For a 0.5 mg L(-1) cut-off, the test sensitivity was 97.4%, but its specificity was only 56.7%. However, PE prevalence increased gradually with DD levels. The true observed PE prevalence, according to the quantitative assessment of DD levels, differed from that predicted with pretest clinical probability only. Moreover, in this well-defined patient group, a quantitative DD level > 2 mg L(-1) was predictive of PE occurrence independently of the clinical score (odds ratio 6.9, 95% confidence interval 3.7, 12.8). As part of a defined strategy, knowledge of positive DD quantitative value, together with the clinical probability score, improves the PE predictive model. A clinical validation of these results in a follow-up study would now be necessary before considering the implementation of this strategy into clinical practice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634271     DOI: 10.1111/j.1538-7836.2004.01045.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  9 in total

Review 1.  Acute pulmonary embolism. Part 1: epidemiology and diagnosis.

Authors:  Renée A Douma; Pieter W Kamphuisen; Harry R Büller
Journal:  Nat Rev Cardiol       Date:  2010-07-20       Impact factor: 32.419

Review 2.  Advances in the diagnosis of venous thromboembolism.

Authors:  Philip S Wells
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

3.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism.

Authors:  Wendy Lim; Grégoire Le Gal; Shannon M Bates; Marc Righini; Linda B Haramati; Eddy Lang; Jeffrey A Kline; Sonja Chasteen; Marcia Snyder; Payal Patel; Meha Bhatt; Parth Patel; Cody Braun; Housne Begum; Wojtek Wiercioch; Holger J Schünemann; Reem A Mustafa
Journal:  Blood Adv       Date:  2018-11-27

4.  Prospective diagnostic accuracy assessment of the HemosIL HS D-dimer to exclude pulmonary embolism in emergency department patients.

Authors:  D Mark Courtney; Justin M Steinberg; Jennifer C McCormick
Journal:  Thromb Res       Date:  2009-06-10       Impact factor: 3.944

5.  Systematic review and meta-analysis of test accuracy for the diagnosis of suspected pulmonary embolism.

Authors:  Parth Patel; Payal Patel; Meha Bhatt; Cody Braun; Housne Begum; Wojtek Wiercioch; Jamie Varghese; David Wooldridge; Hani Alturkmani; Merrill Thomas; Mariam Baig; Waled Bahaj; Rasha Khatib; Rohan Kehar; Rakesh Ponnapureddy; Anchal Sethi; Ahmad Mustafa; Wendy Lim; Grégoire Le Gal; Shannon M Bates; Linda B Haramati; Jeffrey Kline; Eddy Lang; Marc Righini; Mohamad A Kalot; Nedaa M Husainat; Yazan Nayif Al Jabiri; Holger J Schünemann; Reem A Mustafa
Journal:  Blood Adv       Date:  2020-09-22

6.  Complications in COVID-19 patients: Characteristics of pulmonary embolism.

Authors:  Riccardo Cau; Alberto Pacielli; Homayounieh Fatemeh; Paolo Vaudano; Chiara Arru; Paola Crivelli; Giuseppe Stranieri; Jasjit S Suri; Lorenzo Mannelli; Maurizio Conti; Abdelkader Mahammedi; Mannudeep Kalra; Luca Saba
Journal:  Clin Imaging       Date:  2021-05-18       Impact factor: 1.605

7.  D-Dimer Use and Pulmonary Embolism Diagnosis in Emergency Units: Why Is There Such a Difference in Pulmonary Embolism Prevalence between the United States of America and Countries Outside USA?

Authors:  Gilles Pernod; Jeffrey Caterino; Maxime Maignan; Cindy Tissier; Jeannine Kassis; John Lazarchick
Journal:  PLoS One       Date:  2017-01-13       Impact factor: 3.240

Review 8.  Effectiveness of d-dimer as a screening test for venous thromboembolism: an update.

Authors:  Swaroopa Pulivarthi; Murali Krishna Gurram
Journal:  N Am J Med Sci       Date:  2014-10

9.  CT imaging of pulmonary embolism in patients with COVID-19 pneumonia: a retrospective analysis.

Authors:  Irene Espallargas; Juan José Rodríguez Sevilla; Diego Agustín Rodríguez Chiaradía; Antonio Salar; Guillem Casamayor; Judit Villar-Garcia; Anna Rodó-Pin; Salvatore Marsico; Santiago Carbullanca; Diego Ramal; Luis Alexander Del Carpio; Ángel Gayete; José María Maiques; Flavio Zuccarino
Journal:  Eur Radiol       Date:  2020-09-22       Impact factor: 5.315

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.